Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: Lessons from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists

Wojciech Mazur, Grzegorz L. Kaluza, Shelly Sapp, Craig Balog, Eric J. Topol, Daniel B. Mark, Stephen G. Ellis, Dean J. Kereiakes, A. Michael Lincoff, Neal S. Kleiman

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: Lessons from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists'. Together they form a unique fingerprint.

Medicine & Life Sciences